| Dr Shannon Thorn, MD | |
|
2001 W. Orange Grove Rd., Suite 404, Tucson, AZ 85704 | |
| (520) 989-0226 | |
| (520) 989-3798 |
| Full Name | Dr Shannon Thorn |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 21 Years |
| Location | 2001 W. Orange Grove Rd., Tucson, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528268075 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 41117 (Arizona) | Primary |
| 207R00000X | Internal Medicine | A90751 (California) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Medical Center | Tucson, AZ | Hospital |
| Oro Valley Hospital | Oro valley, AZ | Hospital |
| St. Mary's Hospital | Tucson, AZ | Hospital |
| Banner - University Medical Center Tucson Campus | Tucson, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Infectious Disease Of Arizona Pllc | 2466757182 | 6 |
News Archive
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company is in the process of submitting three patent applications for medical safety devices.
In this era of COVID-19, tracking the disease adequately enough to allow state and local officials to lift shelter-in-place orders and return to a semblance of normalcy in the absence of a vaccine will require widespread testing, according to medical experts.
Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more from afatinib than gefitinib as first-line treatment, researchers report at the first ESMO Asia 2015 Congress in Singapore.
According to a recent study, one in five hospital discharges is complicated by an adverse event within 30 days, often leading to emergency care or re-hospitalization. To combat this problem, CIGNA (NYSE:CI) and CareCentrix, Inc., have teamed up to offer the Care Transitions Program to people enrolled in a CIGNA health plan after they've been discharged from the hospital. CareCentrix will provide specialized home nursing services that will help these individuals transition from hospital care to home recovery.
Too few children have received sufficient doses of vaccine to wipe out polio in Pakistan and Afghanistan, two of only three countries in the world where endemic polio has yet to be eliminated, according to new research published Online First in The Lancet. The findings suggest that the newly introduced bivalent oral poliovirus vaccine (OPV) has the potential to eliminate polio in these countries if sufficient numbers of children could be reached by vaccination programmes.
› Verified 2 days ago
| Entity Name | Infectious Disease Of Arizona Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932574498 PECOS PAC ID: 2466757182 Enrollment ID: O20160217002341 |
News Archive
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company is in the process of submitting three patent applications for medical safety devices.
In this era of COVID-19, tracking the disease adequately enough to allow state and local officials to lift shelter-in-place orders and return to a semblance of normalcy in the absence of a vaccine will require widespread testing, according to medical experts.
Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more from afatinib than gefitinib as first-line treatment, researchers report at the first ESMO Asia 2015 Congress in Singapore.
According to a recent study, one in five hospital discharges is complicated by an adverse event within 30 days, often leading to emergency care or re-hospitalization. To combat this problem, CIGNA (NYSE:CI) and CareCentrix, Inc., have teamed up to offer the Care Transitions Program to people enrolled in a CIGNA health plan after they've been discharged from the hospital. CareCentrix will provide specialized home nursing services that will help these individuals transition from hospital care to home recovery.
Too few children have received sufficient doses of vaccine to wipe out polio in Pakistan and Afghanistan, two of only three countries in the world where endemic polio has yet to be eliminated, according to new research published Online First in The Lancet. The findings suggest that the newly introduced bivalent oral poliovirus vaccine (OPV) has the potential to eliminate polio in these countries if sufficient numbers of children could be reached by vaccination programmes.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shannon Thorn, MD 2001 W. Orange Grove Rd., Suite 404, Tucson, AZ 85704 Ph: (520) 989-0226 | Dr Shannon Thorn, MD 2001 W. Orange Grove Rd., Suite 404, Tucson, AZ 85704 Ph: (520) 989-0226 |
News Archive
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company is in the process of submitting three patent applications for medical safety devices.
In this era of COVID-19, tracking the disease adequately enough to allow state and local officials to lift shelter-in-place orders and return to a semblance of normalcy in the absence of a vaccine will require widespread testing, according to medical experts.
Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more from afatinib than gefitinib as first-line treatment, researchers report at the first ESMO Asia 2015 Congress in Singapore.
According to a recent study, one in five hospital discharges is complicated by an adverse event within 30 days, often leading to emergency care or re-hospitalization. To combat this problem, CIGNA (NYSE:CI) and CareCentrix, Inc., have teamed up to offer the Care Transitions Program to people enrolled in a CIGNA health plan after they've been discharged from the hospital. CareCentrix will provide specialized home nursing services that will help these individuals transition from hospital care to home recovery.
Too few children have received sufficient doses of vaccine to wipe out polio in Pakistan and Afghanistan, two of only three countries in the world where endemic polio has yet to be eliminated, according to new research published Online First in The Lancet. The findings suggest that the newly introduced bivalent oral poliovirus vaccine (OPV) has the potential to eliminate polio in these countries if sufficient numbers of children could be reached by vaccination programmes.
› Verified 2 days ago
Dr. Basel Skeif, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5140 E Glenn St, Tucson, AZ 85712 Phone: 520-838-3540 Fax: 520-325-3526 | |
Dr. David Spencer Hamilton Sr., MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 3601 S 6th Ave, Tucson, AZ 85723 Phone: 520-792-1450 | |
Diana Silva Cantillo, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1230 S Cherrybell Stra, Tucson, AZ 85713 Phone: 520-628-8287 | |
Basel Shoua, M.D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2070 W Rudasill Rd Ste 130, Tucson, AZ 85704 Phone: 520-797-4468 Fax: 520-797-4502 | |
Hadil Owaynat, DO Infectious Disease Medicare: Medicare Enrolled Practice Location: 1501 N Campbell Ave Rm 6336, Tucson, AZ 85724 Phone: 520-626-2760 Fax: 520-626-6020 | |
Dr. David M Schwartz, DO Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 6200 N La Cholla Blvd, Tucson, AZ 85741 Phone: 520-469-8011 Fax: 520-469-8021 | |
Kenneth Alex Murachanian, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6060 N Fountain Plaza Dr Ste 270, Tucson, AZ 85704 Phone: 520-229-2578 |